Alpha Arbutin vs Tranexamic Acid

Alpha Arbutin: Targets melanin production; clinical data mainly involve combination creams. Tranexamic Acid: Topical formulas are studied for melasma, with mixed results.

Research updated 2026-10-25
Four alpha arbutin products lined up on white: three dropper serums and a pink cream tubeFive serums lined up on white, labeled tranexamic acid or niacinamide with TXA, including SkinCeuticals Discoloration Defense

Which one is right for you?

Choose Alpha Arbutin if…

Consider for uneven tone; do not assume it matches prescription pigment treatments.

  • Mild uneven tone or dark marks
  • You want a gentler pigment option
  • You use daily sunscreen

Choose Tranexamic Acid if…

Consider a topical pigment option; the evidence is mixed and formula-specific.

  • Melasma or stubborn dark marks
  • Skin that dislikes hydroquinone
  • Daily sunscreen
Often combined

Can you use both?

A gentle pairing for melasma and dark marks. They work in different ways.

At a glance

● Alpha Arbutin
● Tranexamic Acid
Type
Pigment-targeting ingredient
Pigment-targeting ingredient
What it does
Targets melanin production; clinical data mainly involve combination creams.
Topical formulas are studied for melasma, with mixed results.
Best for
Melasma
Melasma
Studied concentrations
A trial used 5% alpha-arbutin plus 2% kojic acid; this is not a recommended home strength.
Topical 5% in the cited trials; oral treatment is a separate medical decision.
When to use
On the schedule specified for the product or prescribed treatment.
On the schedule specified for the product or prescribed treatment.
Time to results
Usually assessed over 8–16 weeks
Usually assessed over 8–16 weeks
Irritation
May cause irritation or a rash; choose a compliant commercial formula.
Can sting or cause redness; do not substitute tablets or injections for a cosmetic product.
Sensitive skin
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Available
Prescription or cosmetic status depends on the active, formula and country; check the label.
Prescription or cosmetic status depends on the active, formula and country; check the label.

What it helps

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Alpha Arbutin
Tranexamic Acid
Limited evidenceEarly or small studies
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

A small trial supports a combined alpha-arbutin and kojic acid cream.
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

Trials report mixed results, including one with no clear benefit over vehicle.
Insufficient evidence
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

Independent benefit for post-acne marks is not established by these studies.
AI-generated educational illustration of Sun Spots: 1. Sun Spots Header — Light Skin; Lighter skin. Not a clinical photograph.

Sun Spots

The cited melasma and laboratory studies do not establish sun-spot clearance.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

The reviewed sources do not establish this ingredient as a treatment for this concern.
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trials do not establish benefit for all post-inflammatory pigment.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Post-Inflammatory Redness.

Post-Inflammatory Redness

The reviewed sources do not establish this ingredient as a treatment for this concern.
A relaxed forehead with faint shallow horizontal fine lines.

Wrinkles and Fine Lines

The reviewed sources do not establish this ingredient as a treatment for this concern.
How it works

Alpha Arbutin

Alpha Arbutin mechanism diagram. Acts on pigment pathways: Laboratory models show reduced tyrosinase activity. Less melanin is made: Topical results depend on the finished formula.
Open full-size diagram
Diagram explanation and sources

Acts on pigment pathways: Laboratory models show reduced tyrosinase activity. Less melanin is made: Topical results depend on the finished formula.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2

Tranexamic Acid

Tranexamic Acid mechanism diagram. Affects plasmin-related signaling: May reduce signals that stimulate pigment production. May help uneven pigmentation: Delivery and the formula influence topical results.
Open full-size diagram
Diagram explanation and sources

Affects plasmin-related signaling: May reduce signals that stimulate pigment production. May help uneven pigmentation: Delivery and the formula influence topical results.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2

Using both in one routine

Built from where each one usually sits in a routine. Introduce one at a time.

Morning
Step 1
Cleanser
Step 2
Alpha ArbutinMorning or night
Step 3
Tranexamic AcidMorning or night
Step 4
Moisturizer
Step 5
Sunscreen
Night
Step 1
Cleanser
Step 2
Alpha ArbutinMorning or night
Step 3
Tranexamic AcidMorning or night
Step 4
Moisturizer

Strengths and forms

Concentrations

Alpha-arbutin percentages need a regional and product-type context. EU cosmetic limits are 2% in face creams and 0.5% in body lotions; these are safety limits, not proven optimal treatment doses.

0.5%

2%

EU body-lotion ceiling

A maximum for the specified EU product category, not a minimum effective concentration.

EU face-cream ceiling

A maximum for the specified EU product category. It does not establish that 2% will work better than every lower-strength formula.

Choosing a strength: Check that the ingredient is alpha-arbutin. Beta-arbutin has different specifications and should not share the same strength scale.

Higher strengths: A higher concentration in a clinical combination study does not override current cosmetic restrictions or establish safe home use.

Formula matters: The extract or ingredient identity, purity and the finished formula matter. Hydroquinone impurities must be controlled.

Topical tranexamic acid studies have used different delivery systems, including 1.8% liposomal lotion and 5% creams or solutions. Oral treatment and procedure-assisted delivery are separate medical decisions.

1.8%

5%

Studied liposomal lotion

One melasma trial tested this delivery system. Its percentage cannot be directly compared with an ordinary serum.

Studied topical formulas

Several melasma studies used topical formulas at this strength. Evidence does not establish one best concentration for all pigment concerns.

Choosing a strength: Look for evidence on the finished topical product. Do not use injectable or oral products as DIY skincare.

Higher strengths: A stronger topical percentage has not been shown to guarantee better results. Oral use requires separate evaluation of risks, including clotting risk.

Formula matters: Liposomal delivery, other brightening ingredients and procedures can change the treatment. A microneedling study is not evidence for the same result from a home serum.

Forms
Serum · Cream
Serum · Tablet · Injection

When you’ll see results

Approximate windows, not promises.

● Alpha Arbutin
● Tranexamic Acid
First few weeks

First few weeksAssess tolerance first; pigment change is usually slower.

First few weeksAssess tolerance first; pigment change is usually slower.

4–8 weeks

4–8 weeksSome studied regimens begin showing pigment improvement.

4–8 weeksSome studied regimens begin showing pigment improvement.

8–12 weeks

8–12 weeksA useful review point for benefit and irritation.

8–12 weeksA useful review point for benefit and irritation.

3–6 months

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

6–12 months

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

Safety and sensitive skin

Common reactions

May cause irritation or a rash; choose a compliant commercial formula.

Can sting or cause redness; do not substitute tablets or injections for a cosmetic product.

When to stop

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Sensitive or inflamed skin

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Important limits

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Pregnancy

Because it releases small amounts of hydroquinone, ask rather than assume; pregnancy-specific data are limited. Ask the doctor managing your pregnancy. Azelaic acid and strict sun protection are the usual suggestions meanwhile.

Melasma is common in pregnancy, so this comes up constantly. Oral tranexamic acid is not a casual pregnancy decision, and the topical version has little pregnancy-specific data. Ask the doctor managing your pregnancy, since they know your full picture.

How it works

In the skin

On the skin. The finished product delivers alpha arbutin in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Laboratory models show reduced tyrosinase activity and melanin production; clinical delivery and formula matter.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

On the skin. The finished product delivers tranexamic acid in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. May affect plasmin-related signalling involved in pigmentation; a small molecular size does not guarantee delivery.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

Getting in
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Molecule size
Alpha Arbutin · 272 Da
Tranexamic Acid · 157 Da
Smaller than 500 Da passes the outer skin more easily. Size isn’t an effectiveness score.
500 Da guideline

Product examples

Alpha Arbutin
  • The Ordinary Alpha Arbutin 2% + HA
  • Naturium Alpha Arbutin Serum 2%
  • COSRX The Alpha-Arbutin 2 Discoloration Care Serum
Tranexamic Acid
  • Anua Dark Spot Correcting Serum — 10% niacinamide and 4% tranexamic acid — a well-chosen pair of pigment actives at a fair price.
  • Naturium Tranexamic Topical Acid — 5% tranexamic acid with kojic acid and niacinamide, for $20. Well built, and no serum fixes melasma alone.

Common questions

Alpha Arbutin:What should I choose alpha arbutin for?

Consider for uneven tone; do not assume it matches prescription pigment treatments.

Alpha Arbutin:How strong is the evidence?

A 30-person split-face trial tested alpha-arbutin together with kojic acid. Laboratory results cannot establish clinical efficacy alone, and nonsignificant differences do not prove equivalence.

Tranexamic Acid:What should I choose tranexamic acid for?

Consider a topical pigment option; the evidence is mixed and formula-specific.

Tranexamic Acid:How strong is the evidence?

A small vehicle-controlled 5% trial did not show superiority over vehicle. A larger active-comparator study found improvement in both groups but did not prove equivalence to hydroquinone.

Sources

Sources and further reading

  1. The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study. (2025)
  2. Inhibitory effects of alpha-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. (2004)
  3. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. (2012)
  4. A Randomized Controlled Study Comparing the Efficacy of Topical 5% Tranexamic Acid Solution versus 3% Hydroquinone Cream in Melasma. (2019)
  5. EU Regulation 2024/996: cosmetic concentration restrictions
  6. SCCS opinion on alpha- and beta-arbutin
  7. Trial of 1.8% liposomal and procedure-assisted tranexamic acid
  8. Randomized trial of topical 5% tranexamic acid
Dermapedia on YouTube